Welcome To The Ondine Biopharma HUB On AGORACOM

Edit this title from the Fast Facts Section

Hub Home

> Log In

Demo Video
Private Messages
Edit My Profile
View/Edit Portfolio

AGORACOM News Flash

AGORACOM WIRE - FRIDAY MAY 25TH, 2012

FOCUS METALS (TSXV:FMS) Changes Its Name to Focus Graphite Inc.

Aim to develop and manufacture the best technology graphite in the world
Additional shareholder value will come from investment in commercialized graphene through joint venture partner, Grafoid Inc.

Read More | *SPONSOR

INTERNATIONAL PBX VENTURES (TSX:PBX) Signs Copaquire Joint Venture Option Agreement - $90M Potential Payment Read More

AGORACOM Maintenance Alert: Friday Evening Downtime for About an Hour Read More

LOMIKO METALS (TSXV:LMR) Graphite and Zinc Price Outlook is Favourable Through 2013 Read More | *SPONSOR

Message: Ondine Announces Presentation of Positive Clinical Trial Results

Reply New Message

« Prev Message Back To Forum Go to Threaded View Next Message »

xanada

Rank: [?]

President

Points: [?]

1933

Rating: [?]

Votes: 9 Score: 3.8

Currently 3.9/5 Stars.

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.

Ondine Announces Presentation of Positive Clinical Trial Results

posted on Sep 05, 08 05:05AM

Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontology's 94th Annual Meeting
Friday September 5, 7:30 am ET

VANCOUVER, Sept. 5 /CNW/ - Ondine Biopharma Corporation (TSX: OBP; AIM: OBP), a medical technology company developing photodisinfection-based products, today announced that a poster entitled "Photodisinfection in the Treatment of Chronic Periodontitis" will be presented by Company representatives at the American Academy of Periodontology's (AAP) annual meeting. This year's AAP meeting is being held at the Washington State Convention and Trade Center in Seattle, Washington on September 6-9, 2008.

"We are pleased to have the opportunity to present photodisinfection to the U.S. periodontal community," said Carolyn Cross, Ondine's President and CEO. "This peer-reviewed poster highlights the positive results of the Company's Multi-Centre Trial using its Photodisinfection System. Periodontal pockets treated with photodisinfection (220mW laser plus photosensitizer) in addition to scaling and root planing (SRP) yielded statistically significant reductions in pocket depth (p=0.01) as well as increases in clinical attachment level (p=0.002) when compared to pockets treated only with SRP."

Reply New Message

« Prev Message Back To Forum Go to Threaded View Next Message »

New Message

Please login to post a reply

Agoracom TV

Check out Agoracom's daily, fast-paced, newscast on the morning's top Small-Cap newsmakers

Mesh With Us On The Web's Top Social Networking Sites

Find Our Content Throughout The Web With Our New Media Partners

AGORACOM Quick Tips

Testimonials. Members Sure Love AGORACOM! ... Get On The List!

Click To Watch Today's Show

President's D.D.

New feature: Hub Presidents can add important links here.

Stock Quote

Open OBP:CA Stock Quote

Investment Ideas

Like Ondine Biopharma? Then you might also be interested in Star Navigation Systems Group Ltd.

Star Navigation Systems Group Ltd.

Developer of the TERRASTARTM in-flight safety monitoring system
The first system in the world to feature real-time in-flight data monitoring and diagnostics
echnical Partnership Agreement with Astrium, a wholly owned subsidiary of EADS

Agoracom